CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • ASCO19 Recap: Caring for Every Patient, Learning from Every Patient

    ASCO19 highlighted a number of immunotherapy developments, including those relating to long-term survival, introducing immunotherapy earlier, biomarkers,…

    June 7, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 5 Update: CAR T Cells for Pleural Cancers and More Melanoma News

    The final day of ASCO19 covered CAR T cells for pleural cancers and long-term updates on several…

    June 5, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 4 Update: Kidney Cancer, Liver Cancer, Stomach Cancer, Esophageal Cancer, and Melanoma

    The fourth day at ASCO19 highlighted immunotherapy strategies for patients with kidney cancer, liver cancer, stomach cancer,…

    June 3, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 3 Update: Immunotherapy for Brain Cancer, Ovarian Cancer, Lung Cancer, and Patients with HIV

    The third day at ASCO19 highlighted immunotherapy strategies for patients with brain cancer, ovarian cancer, lung cancer,…

    June 3, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 2 Update: Biomarkers in Checkpoint Immunotherapy, Targeting Macrophages, and Cellular Immunotherapies

    The second day at ASCO19 highlighted biomarkers that may have value in the context of PD-1 checkpoint…

    June 2, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 1 Update: Lung Cancer, Head and Neck Cancer, and the Cost of Immunotherapy

    The opening day at ASCO19 discussed various immunotherapy combinations for head and neck cancer, a bispecific antibody…

    June 1, 2019| Arthur N. Brodsky, PhD
  • Connecting and learning about immunotherapy in San Francisco

    On June 30, 2018, over 200 patients, caregivers, and advocates gathered to connect with experts and learn…

    July 3, 2018| Caroline Offit
  • 30 Days of CRI Impact: How Bacteria and Vaccines Can Help the Immune System Fight Cancer

    This week’s breakthroughs highlight the benefits of bacteria, vaccines, and the use of immunotherapy earlier in the…

    June 30, 2018| Arthur N. Brodsky, PhD
  • Bikes, Beers, and One Cause to Cure All Cancers

    On June 26, 2018, 48 cyclists—CRI Associate Board members, family, and friends—biked together at SWERVE Fitness Flatiron…

    June 29, 2018| Angela Bui
Previous Page
1 2 3 4 5 6
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute